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Purpose or Objective: The aim of the survey – to compare 
the results of different regimen of whole-breast irradiation 
(accelerated hypofractionated and standard radiation 
treatment) following breast-conserving surgery for breast 
cancer I-IIA stages. 
 
Material and Methods: From 2000 till 2005 203 patients aged 
R54 years received whole-breast irradiation following breast-
conserving surgery (lumpectomy + axillary and internal 
lymphatic dissection). The most commonly seen invasive 
ductal carcinoma (55%), the rare - invasive lobular carcinoma 
(27%), invasive ductal cancer with extensive in situ 
component (3%) and special forms (15%). Metastasis in 
ipsilateral axillary lymph nodes fixed in 17,4% cases. All 
patients received whole-breast irradiation over a five-day 
period with different regimens RT: first group - accelerated 
hypofractionated (AHRT: 3 Gy per fraction over 2,5 weeks, 
total dose of 39 Gy, N=112) and second group - standard 
radiotherapy (SRT: 2Gy per fraction over 5 weeks, total dose 
of 50 Gy, N=91). We used three dimensional CT-based 
treatment planning, two traditional tangential fields 6-18 MV, 
changing the gantry angle, collimator angle, blocks to result 
in coverage of the breast while excluding the heart from the 
treatment fields and minimized dose to the lung. A LQM to 
predict rate of tumor control, late normal tissue effects and 
cosmetic outcome was used in our research. For tumor 
control the value α/β was 4 Gy, acute toxicity – 10 Gy, side 
effects - 3,1 Gy, cosmetic outcome - 3,6 Gy (for AHRT EQD2 
53,0/44,4/46.7/46,0). We calculate (LQM) following formula 
for AHRT:  
 
 
Tumor: k=0,7, Tk=21. 
 
Results: Local recurrence at 5y/10y: 1/3 (1 group) vs 0/1 (2 
group) (p>0.05). Overall survival 5y/10y: 99,1%/95,0% (1 
group) vs. 97,8%/85,0% (2 group), (p<0.05).. Only 8% of the 
patients of the 1 group developed grade 2 erythema and 
14,3% of the patients of the 2 group (p<0,048). No 
complications at heart, сomplications at the lungs (only 1 
degree) 5y/10y: 7(7,7%)/7(7,7%) vs. 6 (5,4%)/6(5,4). The 
other results are presented in Table 1.  
Table 1 (5 and 10 year outcome). 
 
 
 
Conclusion: AHRT decrease adverse effects, increase five 
and ten-year event free survival and cosmetic results vs. SRT. 
We had confirmed our calculations with clinical results. AHRT 
had been proved to be a successful parameters combination 
of a dose for fraction, durations of an irradiation and the 
common dose. Prominent feature of this regimen is increase 
of the tumor control in comparison with SRT, thus early and 
late reactions are essentially decreased 
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Purpose or Objective: To assess the magnitude of inter-
observer contouring uncertainties on CT- and MRI-based boost 
volume contouring in breast cancer patients without clips in 
lumpectomy cavity. 
 
Material and Methods: CT and MRI data-sets of 12 
consecutive patients, treated with surgery (no clips in 
lumpectomy cavity) and postoperative irradiation were 
included. Five experienced radiation oncologists 
independently contoured the boost clinical target volume 
(CTVb) on CT. Three weeks later contouring was repeated on 
MRI. Finally, expert consensus (EC) contours were created on 
both modalities by combining the opinions of all 5 experts. 
Contour Analysis software Tool 1 (CAT 1) was used for global 
volumetric computations and assessment of local contouring 
variation for each case and contouring approach. Inter-
observer volumetric conformity index (VCI) was calculated 
for all pairs of observer’s delineations and the EC contour. In 
topographic analysis, absolute inter-delineation distances 
(IDDs) between observers’ and EC delineations were 
measured in contouring plane (Figure). Paired sample t-test 
was used to for statistical analysis of differences between 
contouring approaches. 
 
Results: None of the observed differences in results were 
statistically significant (p>0.05). Mean CTVb size was 154 +/- 
26 cm3, and 152 +/- 16 cm3, for CT and MRI, respectively. 
Mean relative standard deviation (rSD) revealed higher spread 
of volumes for CT (18 %) when compared with MRI (11 %). 
Mean ratio between the smallest and largest volume was 
comparable (CT: 0.7 +/- 0.1; MRI: 0.8 +/- 0.1). Mean VCI was 
non-significantly higher for MRI (0.81 +/- 0.04) than CT (0.76 
+/- 0.07). MRI-based mean VCI was superior to CT-based 
approach in 10 (83 %) cases. In one case, mean VCI was 
identical (0.88 +/- 0.1), and in one case CT-based VCI (0.81 
+/- 0.04) was slightly superior to MRI (0.8 +/- 0.05). Analysis 
of mean IDD values revealed non-significantly superior results 
for MRI when compared to CT (3 +/- 0.5 mm vs. 4 +/- 1.5 
mm) (Figure). Mean rSD for IDDs was lower on MRI than CT 
contouring (49 % vs. 61 %). In contouring plane, predilection 
regions of variation were in the direction of breast 
parenchyma, while agreement was highest at the breast-
chest wall and breast-air interface (Figure).  
 
 
 
Figure. Example of coordinate system (left) and distance 
maps (right) or topographic assessment of variation.  
 
Conclusion: Although statistically insignificant, superiority of 
MRI over CT for accurate boost delineation in patients 
without clips in lumpectomy cavity may be clinically 
important. We recommend using information from both 
modalities, pre-treatment imaging and clinical information to 
arrive at best results. 
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Purpose or Objective: Our institute started a clinical study 
on radical C-ion RT for patients with low risk T1N0M0 invasive 
